Stocks · Health care · Pharmaceutical Preparations

ALX ONCOLOGY HOLDINGS INC

ALXO Clue Score32
United States Fiscal year ends December CIK 0001810182 Results filed 6 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Sophia Randolph
9 Jun 2023
Chief Medical Officer
Exercised, kept
6,256
$4.81
$30.09K
Sophia Randolph
9 Jun 2023
Chief Medical Officer
Exercised, kept
2,546
$4.08
$10.39K
Sophia Randolph
9 Jun 2023
Chief Medical Officer
Exercised, kept
4,027
$1.91
$7.69K
Sophia Randolph
16 Dec 2022
Chief Medical Officer
Exercised, kept
25,339
$4.81
$121.88K
Sophia Randolph
16 Dec 2022
Chief Medical Officer
Exercised, kept
12,731
$4.08
$51.94K
Sophia Randolph
16 Dec 2022
Chief Medical Officer
Exercised, kept
8,404
$1.91
$16.05K
Peter S Garcia
7 Feb 2022
Chief Financial Officer
Exercised, kept
8,363
$4.81
$40.23K
Peter S Garcia
7 Feb 2022
Chief Financial Officer
Exercised, kept
6,637
$4.08
$27.08K
Jaume Pons
3 Feb 2022
President & CEO
Exercised, kept
12,254
$1.91
$23.41K
Jaume Pons
3 Feb 2022
President & CEO
Exercised, kept
11,900
$0.99
$11.78K
Sophia Randolph
15 Dec 2021
Chief Medical Officer
Exercised, kept
11,059
$1.91
$21.12K
Sophia Randolph
15 Dec 2021
Chief Medical Officer
Exercised, kept
12,793
$0.99
$12.67K
Jaume Pons
25 Mar 2021
President & CEO
Exercised, kept
10,000
$0.99
$9.90K
Peter S Garcia
28 Jan 2021
Chief Financial Officer
Exercised, kept
6,128
$4.08
$25.00K
Jaume Pons
26 Jan 2021
President & CEO
Exercised, kept
10,000
$0.99
$9.90K

What was left out

Form 4 filings counted 187
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 5
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 37
Sales at will 148
Transactions with no price 0
Shares from compensation/vesting 28,133,470
Sales filed before the plan box existed 114
History held since 17 Jul 2020